CompletedNCT00159744
3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008)
This study is completed. It focuses on bipolarity and currently lists study information in Global.
In GlobalBipolarityOtherOver 18 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT00159796
3-week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07009)
This study is completed. It focuses on bipolarity and currently lists study information in Global.
In GlobalBipolarityOtherOver 18 Years
CompletedNCT00312494
Ziprasidone With Either Lithium or Divalproex for Bipolarity
This study is completed in the United States. It is testing ziprasidone With Either Lithium or Divalproex for Bipolarity.
Multiple locations, including DothanBipolarityOtherFrom 18 Years to 65 Years
CompletedNCT03796936
3MDR to Treat PTSD With mTBI (3MDR)
This study is completed. It focuses on PTSD and currently lists study information in the United States.
In BethesdaPTSDBehavioralOver 18 Years
Active Not RecruitingNCT06912750
4-7-8 Breathing and Teach-Back Method for Pain, Anxiety, and Sleep After Knee Surgery: A study
This study is active but not recruiting. It focuses on anxiety and currently lists study information in Turkey.
In ErzurumAnxietyBehavioralFrom 18 Years to 70 Years
CompletedNCT00159783
40 Week Extension Study Of Asenapine and Olanzapine For Bipolarity (A7501007)(COMPLETED)(P05857)
This study is completed. It focuses on bipolarity and currently lists study information in Global.
In GlobalBipolarityOtherOver 18 Years
CompletedNCT00145509
40 Week study to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolarity (A7501009)(P05786)
This study is completed in Global. It focuses on Bipolarity.
In GlobalBipolarityOtherOver 18 Years
Enrolling By InvitationNCT07059143
6 Weeks Right-Amygdala TIS for Depression
This study is enrolling by invitation. It focuses on depression and currently lists participation information in China.
Multiple locations, including GuangdongDepressionOtherFrom 18 Years to 60 Years
CompletedNCT00265343
6-Month Extension study of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the Protocol 25543 (25544)(P05777)
This study is completed. It focuses on schizophrenia and currently lists study information in Global.
In GlobalSchizophreniaDrugA study involving a medication or substance.Over 18 Years
CompletedNCT00174265
6-Month Extension study of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month study (A7501014)(COMPLETED)(P05772)
This study is completed in Global. It focuses on Schizophrenia.
In GlobalSchizophreniaDrugOver 18 Years
CompletedNCT01098110
Asenapine Compared to Placebo for schizophrenia
This study is completed in Global. It is testing asenapine Compared to Placebo for schizophrenia.
In GlobalSchizophreniaOtherFrom 20 Years to 64 Years
CompletedNCT01861847
7-Keto DHEA for PTSD
This study is completed. It focuses on PTSD and currently lists study information in the United States.
In Bay PinesPTSDDrugFrom 18 Years to 64 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.